about
ACE2 activation promotes antithrombotic activity.LPA receptor signaling: pharmacology, physiology, and pathophysiology.Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 productionSpectral imaging reveals microvessel physiology and function from anastomoses to thromboses.Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modelingSupplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults.Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease.Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilizationPlatelets in inflammation and atherogenesis.Platelets modulate atherogenesis and progression of atherosclerotic plaques via interaction with progenitor and dendritic cells.Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease.Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.A genome- and phenome-wide association study to identify genetic variants influencing platelet count and volume and their pleiotropic effects.Renal artery stenosis and mean platelet volume.Exploring hypertension genome-wide association studies findings and impact on pathophysiology, pathways, and pharmacogenetics.Medicinal Plants with Antiplatelet Activity.Cellular recruitment in myocardial ischaemia/reperfusion injury.Platelets and von Willebrand factor in atherogenesis.Antioxidants change platelet responses to various stimulating events.The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets.Attenuation of Thrombosis by Crude Rice (Oryza sativa) Bran Policosanol Extract: Ex Vivo Platelet Aggregation and Serum Levels of Arachidonic Acid MetabolitesIncreased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic ratAn orally active formulation of angiotensin-(1-7) produces an antithrombotic effect.Association of human platelet antigens polymorphisms with susceptibility to hepatitis C virus infection in Chinese population.Antagonism of P2Y₁₂ reduces physiological thromboxane levels.Effect of tomato industrial processing on phenolic profile and antiplatelet activity.Unconjugated bilirubin inhibits collagen induced platelet activation.Buddleja globosa (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signaling.Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration.Platelet activation in chronic cocaine users: effect of short term abstinence.Impact of specific functional groups in flavonoids on the modulation of platelet activation.
P2860
Q33611250-184DEB9F-F48E-470F-B495-D71DC824ABD9Q33825153-7A28FB2D-9061-4F0B-BA55-F3D91D9EB6FAQ34047510-0853FCF3-85A1-4391-8600-09E335907BA3Q34049847-BE51B193-82AA-448A-8253-24BE47C5A977Q34506411-ABF3FFDB-BB60-476C-954E-40A461AB761AQ35324960-B63DF9EF-11CC-4145-BC06-8F7AF80A628DQ35505135-87147AA8-63A1-4410-BB54-EF6F364D4575Q35995270-568CCB8D-76A5-47B8-ACAD-99A0BAAF21C9Q36328825-38EE1C7A-FC73-40CE-A4D1-5EB3638D8188Q37035357-2AF73141-0393-48B7-98CA-EC6EBC8620DDQ37218342-9ABC6E35-F463-41EB-8DB7-E2DEAC888DC1Q37334893-84B3D774-0E83-4A4E-A7E8-321479B27A0CQ37432574-3C1ED50B-49CD-4720-B198-C364F85BDA9CQ37680360-D48ADF1C-23B7-4427-92E5-D44A078BCB96Q38345519-364D99FC-31D4-4643-92C2-BB6BFED9FA33Q38803630-AF3CB3B6-3F61-440E-8B64-8C985C0E2F48Q38811208-0AA81396-8692-4C71-97CF-D50F4E1C1B50Q39125083-1DCDA1F5-FA6E-43B5-9148-614D103E8AC9Q40017206-07531348-52A4-431C-92D5-E7CB64C15565Q40119975-0D04A68A-25B7-41B1-A646-690A6D43C123Q41496359-D1E5BBD6-8E0C-4C57-A8CD-73C96F2CBE53Q41584099-1584B73C-CDAD-4A37-91C9-DDF69AF11DC8Q41830683-CAB8ACE0-BAB4-45B1-A842-E545EB440F6FQ41934049-E653DFF0-0110-43DD-AEF7-F33037F1B425Q42822978-ECF07B68-A740-46EB-81E5-6C44ED419548Q44361584-844CE3D3-0F41-4BB1-A4DA-15BE97AE3290Q46202266-DC261685-5B5E-45BC-BED0-17D20AEE8640Q47398058-6746E0EE-C01C-42B1-9EB8-73C9E6E794BFQ47828127-A865D3D9-1F34-4B76-A69F-7FD718EA7B84Q48242661-BF847248-8F9F-4FE3-82F3-0C185FE32CD9Q55445847-EBA6233C-4F72-4F78-9DAD-6ED378995B8F
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Platelets and cardiovascular disease.
@ast
Platelets and cardiovascular disease.
@en
type
label
Platelets and cardiovascular disease.
@ast
Platelets and cardiovascular disease.
@en
prefLabel
Platelets and cardiovascular disease.
@ast
Platelets and cardiovascular disease.
@en
P1476
Platelets and cardiovascular disease.
@en
P2093
Andrew Holmes
Scott Willoughby
P304
P356
10.1016/S1474-5151(02)00038-5
P577
2002-12-01T00:00:00Z